Technology News and Research

RSS

Autism Speaks: Ten most significant autism research achievements in 2009

Autism Speaks, the world's largest autism science and advocacy organization has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year. Every year, Autism Speaks documents the progress made toward its mission to discover the causes and treatment for autism spectrum disorders, and compiles a list of the 10 most significant research achievements to have impacted autism during the previous year.

10 Feb 2010

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).

10 Feb 2010

Laser Spine Institute recognized as ‘Medical Partner of the Year’

This year, Gridiron Greats recognized LSI at the event as Medical Partner of the Year. LSI's medical director Dr. Michael Perry and CEO Bill Horne accepted the award.

10 Feb 2010

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Elan Corporation, plc today reported its fourth quarter and full-year 2009 financial results and provides financial guidance for 2010.

10 Feb 2010

Sony acquires iCyt Mission Technology

Sony Corporation (Sony) announced today that it has acquired iCyt Mission Technology, Inc. (iCyt), a leading producer of high-performance cell sorters used for stem cell and disease research, through its U.S. subsidiary, Sony Corporation of America (SCA).

10 Feb 2010

SPO Medical signs Memorandum of Understanding with SporTracker

SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced it has signed a Memorandum of Understanding (MOU) with SporTracker Ltd, a private Israeli company that specializes in the integration of heart-rate monitoring with consumer audio and leisure devices.

10 Feb 2010

St. Jude Medical's USB cellular adaptor receives European CE Mark approval for Merlin@home transmitter

St. Jude Medical, Inc. today announced European CE Mark approval of its USB cellular adaptor for the Merlin@home™ transmitter, a system that allows important patient data from an implantable cardiac device to be wirelessly downloaded and securely transmitted via telephone for review by a physician.

10 Feb 2010

MSU launches research and training program to address product counterfeiting

Michigan State University has launched the nation's first comprehensive research and training program designed to address product counterfeiting-- which the FBI has called "the crime of the 21st century."

10 Feb 2010

Stryker Orthopaedics announces the release of Rejuvenate Modular Primary Hip System

Stryker Orthopaedics today announced the release of its Rejuvenate Modular Primary Hip System, which is designed to help recreate the anatomy and hip biomechanics of individual patients.

From Stryker 10 Feb 2010

OlFactor Laboratories acquires exclusive license to patented technology from UC Riverside

OlFactor Laboratories, Inc., a majority owned subsidiary of Avisio, Inc. acquired an exclusive license to patented technology from UC Riverside.

10 Feb 2010

US HIFU announces exclusive partnership with Riverside Research Institute

US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research Institute (RRI) to develop and test an ultrasonic method of prostate imaging and treatment that combines advanced tissue-type imaging with ultrasound energy from the Sonablate® 500 medical device.

10 Feb 2010

Ligon Discovery, Lycera announce collaboration to identify drug candidates for immune disorders

Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.

10 Feb 2010

New Multi-Cycle program reduces risk of infertility treatment for older mothers

Fertility experts at the Reproductive Science Center of the Bay Area (RSC) announced they have launched a new program from IntegraMed geared toward easing the risk of infertility treatment for qualified women of ages 49 and younger who want to use their own eggs in order to achieve pregnancy.

10 Feb 2010

FDA grants marketing clearance for Volcano's Eagle Eye Platinum digital IVUS catheter

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.

9 Feb 2010

Surgical 'checklist' saves money, lives

The Newshour has a transcript of a feature report on Dr. Atul Gawande's new book, "The Checklist Manifesto: How to Get Things Right," which "grew out of work he did for the World Health Organization, which asked him to help them find a way to reduce deaths in surgery."

9 Feb 2010

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.

9 Feb 2010

Cynosure settles patent infringement lawsuit against CoolTouch

Cynosure, Inc., developer of the award-winning Smartlipo™ LaserBodySculpting(SM) procedure for minimally invasive removal of fat, and its largest shareholder, El.En. S.p.A, today announced a settlement of their patent infringement lawsuit against CoolTouch, Inc. Cynosure and El.En. alleged that CoolTouch's 1320 nm CoolLipo™ laser system infringed on El.En.'s U.S. Patent No. 6,206,873 (the 873 patent) licensed to Cynosure, which covers laser technology to remove subcutaneous fat.

9 Feb 2010

Fourth-quarter and full-year 2009 results announced by Cynosure

Cynosure, Inc., a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced financial results for the three and 12 months ended December 31, 2009.

9 Feb 2010

Chi-Fu Trading to market and sell Delcath PHP Systems in Taiwan

Delcath Systems, Inc. (DCTH), a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today the signing of its first research, distribution, sales and marketing agreement for its Percutaneous Hepatic Perfusion (PHP) System (the Delcath PHP System™). The agreement grants Chi-Fu Trading Co., Ltd. the exclusive right to market and sell the Delcath PHP System in Taiwan for hepatic malignancies and infectious disease upon Taiwan Food and Drug Administration (TFDA) approval, and any other approved use, with a conditional option for Singapore.

9 Feb 2010

Hoya reports financial results for quarter ended December 31, 2009

Hoya Corporation today announced financial results for the third quarter ended December 31, 2009. Net sales were 106.8 billion yen for the quarter, a 5.2% decrease from 112.7 billion yen in the same period last year. Operating income was 18.9 billion yen, a 13.8% increase from 16.6 billion yen in the same period last year, mainly due to increase in orders and productivity. Compared to the second quarter ended September 30, 2009, sustained recovery in orders since April resulted in an increase of both net sales and operating income.

9 Feb 2010

Technology News and Research

Autism Speaks: Ten most significant autism research achievements in 2009

Sequenom CMM licenses rights from Optherion to develop and commercialize AMD diagnostic tests

Laser Spine Institute recognized as ‘Medical Partner of the Year’

Elan announces fourth-quarter and full-year financial results ended December 31, 2009

Sony acquires iCyt Mission Technology

SPO Medical signs Memorandum of Understanding with SporTracker

St. Jude Medical's USB cellular adaptor receives European CE Mark approval for Merlin@home transmitter

MSU launches research and training program to address product counterfeiting

Stryker Orthopaedics announces the release of Rejuvenate Modular Primary Hip System

OlFactor Laboratories acquires exclusive license to patented technology from UC Riverside

US HIFU announces exclusive partnership with Riverside Research Institute

Ligon Discovery, Lycera announce collaboration to identify drug candidates for immune disorders

New Multi-Cycle program reduces risk of infertility treatment for older mothers

FDA grants marketing clearance for Volcano's Eagle Eye Platinum digital IVUS catheter

Surgical 'checklist' saves money, lives

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Cynosure settles patent infringement lawsuit against CoolTouch

Fourth-quarter and full-year 2009 results announced by Cynosure

Chi-Fu Trading to market and sell Delcath PHP Systems in Taiwan

Hoya reports financial results for quarter ended December 31, 2009

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News